Pages that link to "Q36963020"

The following pages link to Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus. (Q36963020):

Displaying 22 items.

• Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment (Q28066904) (← links)
• Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience (Q38599122) (← links)
• Targeted Therapies in Thyroid Cancer: An Extensive Review of the Literature (Q38883187) (← links)
• Molecular profiling of renal cell carcinoma: building a bridge toward clinical impact (Q38910995) (← links)
• Applications of molecular testing in surgical pathology of the head and neck (Q39070411) (← links)
• Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation (Q41050010) (← links)
• Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma (Q42698863) (← links)
• Dramatic Response to Carboplatin, Paclitaxel, and Radiation in a Patient With Malignant Myoepithelioma of the Breast (Q46525101) (← links)
• The PI3K Pathway in Human Disease (Q46546002) (← links)
• Biomarkers of Everolimus Sensitivity in Hormone Receptor-Positive Breast Cancer (Q47101508) (← links)
• mTOR Cross-Talk in Cancer and Potential for Combination Therapy. (Q48530866) (← links)
• The Role of Circulating Tumor DNA in Renal Cell Carcinoma (Q49722631) (← links)
• Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells. (Q52584369) (← links)
• Not only stem cells, but also mature cells, particularly neuroendocrine cells, may develop into tumours: time for a paradigm shift. (Q55313360) (← links)
• Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy (Q64246248) (← links)
• Current Coverage of the mTOR Pathway by Next-Generation Sequencing Oncology Panels (Q64275018) (← links)
• mTOR in Lung Neoplasms (Q89523557) (← links)
• Therapeutic implications of germline genetic findings in cancer (Q91728273) (← links)
• Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice (Q92372097) (← links)
• Everolimus-containing therapy vs conventional therapy in the treatment of refractory breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study (Q92442367) (← links)
• Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer (Q92824043) (← links)
• Genomics-Enabled Precision Medicine for Cancer (Q92830555) (← links)